1. Home
  2. RCEL vs USCB Comparison

RCEL vs USCB Comparison

Compare RCEL & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • USCB
  • Stock Information
  • Founded
  • RCEL 2020
  • USCB 2002
  • Country
  • RCEL United States
  • USCB United States
  • Employees
  • RCEL N/A
  • USCB N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • USCB Major Banks
  • Sector
  • RCEL Health Care
  • USCB Finance
  • Exchange
  • RCEL Nasdaq
  • USCB Nasdaq
  • Market Cap
  • RCEL 308.6M
  • USCB 353.0M
  • IPO Year
  • RCEL N/A
  • USCB 2021
  • Fundamental
  • Price
  • RCEL $8.73
  • USCB $18.78
  • Analyst Decision
  • RCEL Buy
  • USCB Buy
  • Analyst Count
  • RCEL 5
  • USCB 4
  • Target Price
  • RCEL $18.00
  • USCB $16.13
  • AVG Volume (30 Days)
  • RCEL 251.2K
  • USCB 26.6K
  • Earning Date
  • RCEL 02-13-2025
  • USCB 01-23-2025
  • Dividend Yield
  • RCEL N/A
  • USCB 1.06%
  • EPS Growth
  • RCEL N/A
  • USCB 13.14
  • EPS
  • RCEL N/A
  • USCB 1.04
  • Revenue
  • RCEL $60,040,000.00
  • USCB $71,791,000.00
  • Revenue This Year
  • RCEL $36.71
  • USCB N/A
  • Revenue Next Year
  • RCEL $54.48
  • USCB $15.26
  • P/E Ratio
  • RCEL N/A
  • USCB $18.07
  • Revenue Growth
  • RCEL 32.24
  • USCB 10.04
  • 52 Week Low
  • RCEL $7.51
  • USCB $10.25
  • 52 Week High
  • RCEL $18.93
  • USCB $21.86
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 31.80
  • USCB 58.40
  • Support Level
  • RCEL $8.53
  • USCB $16.01
  • Resistance Level
  • RCEL $9.42
  • USCB $18.42
  • Average True Range (ATR)
  • RCEL 0.65
  • USCB 0.58
  • MACD
  • RCEL -0.39
  • USCB 0.17
  • Stochastic Oscillator
  • RCEL 3.89
  • USCB 97.54

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.

Share on Social Networks: